IgE-retargeting, Function-Altering Molecules (ERFAM) for treatment of allergic diseases

Details for Australian Patent Application No. 2005300261 (hide)

Owner Imperial College Innovations Limited St. Mary's Hospital NHS Trust

Inventors Turcanu, Victor; Lack, Gideon

Agent Cullen & Co

Pub. Number AU-A-2005300261

PCT Pub. Number WO2006/048781

Priority 60/572,821 20.05.04 US

Filing date 19 May 2005

Wipo publication date 11 May 2006

International Classifications

A61K 31/00 (2006.01)

Event Publications

4 January 2007 PCT application entered the National Phase

  PCT publication WO2006/048781 Priority application(s): WO2006/048781

26 March 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005300263-Autogenic living scaffolds and living tissue matrices: methods and uses thereof

2005300259-Wrapping sheet bonded together and methods of making and using the same